420 with CNW — Another Federally Backed Study Finds Recreational Marijuana Legalization Doesn’t Increase Youth Use

A recent study supported by federal funds has found no clear link between the legalization of cannabis for adult use and an increase in its consumption among middle schoolers.

To investigate the impact of legal sales on youth usage, researchers conducted a comparative analysis of middle-school usage rates in New Mexico and Nevada, utilizing data from state-conducted surveys in 2017 and 2019. Notably, during this period, Nevada permitted adult-use cannabis sales while New Mexico restricted its use to medical purposes only.

Across both states, the study uncovered rises in the percentages of middle schoolers who had experimented with marijuana and those who reported using it within the past month.

In Nevada, the proportion of students admitting to ever trying marijuana increased from 9.7% in 2017 to 13.3% in 2019. Similarly, past 30-day usage surged from 6.3% to 8.9%. Meanwhile, in New Mexico, lifetime usage rose from 14.1% to 17.4%, with past 30-day usage climbing from 8.9% to 10.5%.

Despite these concerning trends, researchers refrained from directly attributing the rise to legalization. They stated that they didn’t discover convincing evidence linking cannabis legalization with an immediate spike in use among middle school students in Nevada, which is consistent with earlier research.

However, they deemed the general rise in cannabis use among middle-schoolers in both New Mexico and Nevada within the said period troubling due to the known health risks associated with early initiation of cannabis use.

The study, which was supported by a grant from the National Institute on Drug Abuse (NIDA), involved cooperation between researchers from the New Mexico Health Department and the universities of New Mexico and Nevada. Analysis across the two states revealed that female students, individuals of nonwhite ethnicity and those attending low-income Title I schools exhibited higher likelihoods of both past 30-day and lifetime marijuana usage.

The authors suggested that their findings were consistent with existing literature, which suggests that cannabis usage might serve as a coping mechanism for discrimination and poverty, with adolescent females increasingly reporting higher usage rates compared to males.

In terms of policy implications, the study underscored the importance of targeting prevention efforts toward groups at heightened risk rather than solely focusing on the legal status of cannabis for adults.

However, the researchers acknowledged certain limitations of their study, including the inability to account for the potential influence of neighboring states with differing marijuana policies, such as California and Colorado. Additionally, the study did not delve into the frequency of usage or changes in marijuana use disorder.

Several studies have been published dispelling the misconception that cannabis legalization permitting companies such as SNDL Inc. (NASDAQ: SNDL) to operate results in more teens accessing marijuana products. The data is consistent in showing that this isn’t the case.

About CNW420

CNW420 spotlights the latest developments in the rapidly evolving cannabis industry through the release of an article each business day at 4:20 p.m. Eastern – a tribute to the time synonymous with cannabis culture. The concise, informative content serves as a gateway for investors interested in the legalized cannabis sector and provides updates on how regulatory developments may impact financial markets. If marijuana and the burgeoning industry surrounding it are on your radar, CNW420 is for you! Check back daily to stay up-to-date on the latest milestones in the fast -changing world of cannabis.

To receive SMS alerts from CNW, text CANNABIS to 888-902-4192 (U.S. Mobile Phones Only)

For more information, please visit https://www.CannabisNewsWire.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: https://www.CannabisNewsWire.com/Disclaimer

CannabisNewsWire
Denver, CO
www.CannabisNewsWire.com
303.498.7722 Office
Editor@CannabisNewsWire.com

CannabisNewsWire is powered by IBN

420 with CNW — Virginia Lawmakers Pass Cannabis Sales Bill, Send to Governor

Virginia lawmakers have recently given their final nod to legislation aiming to legalize the retail sale of cannabis, slated to commence from May 1, 2025. This decision, following several weeks of negotiations, now awaits the approval of Governor Glenn Youngkin.

Both the Senate and House of Delegates endorsed similar versions of the measures on Feb. 28, 2024, reconciling differences after amendments from a committee in the Senate threatened to disrupt the agreement between the two chambers. Later, each chamber approved the bills from the other, forwarding them to the governor for potential enactment.

A prior Democratic-led measure from 2021 allowed for the possession, use and restricted cultivation of marijuana in Virginia. However, GOP legislators obstructed the necessary reconstruction of regulations for retail sales when they took control of the governor’s office and the House, which resulted in the creation of illegal establishments to satisfy consumer demand.

Even with legislative approval, retail sales are not guaranteed to be legal. While Youngkin has not stated whether he intends to veto the measure, he made it clear last month that he was not interested in legalizing Democratic-led cannabis sales.

Democrats introduced competing bills (SB 448 and HB 698), but in recent weeks, law makers have worked towards consensus and compromise. This week marked the culmination of multiple amendments in committees and on both floors until a consensus was eventually reached.

While there were some parallels between the prior versions of the laws, there were also notable differences, including the approach to social equality, the taxation rate, the opening time for retail establishments and the authorization for outdoor marijuana growing. The tax issue was the final obstacle before the votes. Last week, a compromise was proposed that would impose a 9% tax on cannabis sales — 4.5% state tax and an optional 4.5% local tax. However, a committee in the Senate broke from the agreement, raising the tax rate in HB 698 to a little more than 17%.

Subsequent floor amendments in both chambers then restored harmony to the tax provisions. As a result, the combined tax rates for both measures are now 11.625% — 8% state tax, 2.5% optional local tax and 1.125% state sales taxes to fund education.

The measures narrowly passed both chambers. The Senate passed HB 698 by a vote of 21 to 18, while the House approved SB 448 by a 51-to-47 vote. The amended measures were later approved by both chambers by the same voting margins.

The entire cannabis industry, including leading companies such as SNDL Inc. (NASDAQ: SNDL), is likely to welcome the eventual launch of recreational marijuana sales in Virginia as that would be a major step forward in rolling back prohibition.

About CNW420

To receive SMS alerts from CNW, text CANNABIS to 888-902-4192 (U.S. Mobile Phones Only)

For more information, please visit https://www.CannabisNewsWire.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: https://www.CannabisNewsWire.com/Disclaimer

CannabisNewsWire
Denver, CO
www.CannabisNewsWire.com
303.498.7722 Office
Editor@CannabisNewsWire.com

CannabisNewsWire is powered by IBN

420 with CNW — Pennsylvania Bill Seeks to Allow Medical Cannabis Users to Own Guns

Pennsylvania’s Erie GOP Senator Dan Laughlin is initiating a measure to change the gun ownership laws, enabling medical cannabis users to possess firearms. Laughlin argues that Second Amendment rights shouldn’t be violated because medical marijuana is a legitimate treatment for symptoms. Laughlin notes that the amendment is aimed at defending constitutional rights and personal liberty.

However, changing state laws will not be enough because federal law forbids marijuana users from owning firearms. The senator, who is surprised by the federal government’s passivity, takes inspiration from a case filed by the district attorney of Warren County against federal limits.

Robert Greene, the district attorney for Warren County and a certified medical marijuana patient in Pennsylvania, filed a lawsuit against the government about the prohibition of gun ownership by cannabis consumers.

Pennsylvania Family Institute President Michael Geer opposes Laughlin’s effort, citing possible risks associated with combining marijuana and firearms. Without recommended amounts, he claims, users run the risk of misuse, especially when using high-THC cannabis products.

Nevertheless, Laughlin, who humorously acknowledges his role as a leading advocate for marijuana legalization within the GOP, remains undeterred. Last year, Laughlin wrote to Pennsylvania’s acting police commissioner, asking him to review a federal decision that declared the federal prohibition on cannabis users owning firearms to be unlawful.

The senator’s advocacy for medical marijuana patients’ gun rights comes as state officials contemplate the legalization of recreational cannabis. Recently, Governor Josh Shapiro’s budget proposal called on legislators to move forward with legalizing cannabis for recreational use, emphasizing the need to stay up-to-date with surrounding states.

There is a growing interest in legalizing recreational cannabis in both chambers, with Laughlin leading the legalization reforms in the senate. The House of Representatives, which is now controlled by Democrats, has had several hearings on the issue. A recent poll reveals substantial public support for recreational cannabis legalization in Pennsylvania, with approximately two-thirds of voters endorsing the policy change.

Meanwhile, federal and state laws that prohibit drug users from purchasing firearms have presented challenges for authorities and Second Amendment supporters as more jurisdictions legalize cannabis. Notably, federal law stipulates that it is illegal to purchase or carry a firearm if one uses cannabis or any other restricted narcotic.

However, the act that gave rise to that ban has recently been contested in several courts, with some ruling that the restriction is unconstitutional.

The DOJ has staunchly supported the policy, arguing that people who use cannabis present distinct risks to society that warrant denying them their Second Amendment rights.

This bill is likely to be of interest to many cannabis companies such as SNDL Inc. (NASDAQ: SNDL) as its outcome could set a precedent that many other jurisdictions with medical marijuana markets may try to emulate.

About CNW420

To receive SMS alerts from CNW, text CANNABIS to 888-902-4192 (U.S. Mobile Phones Only)

For more information, please visit https://www.CannabisNewsWire.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: https://www.CannabisNewsWire.com/Disclaimer

CannabisNewsWire
Denver, CO
www.CannabisNewsWire.com
303.498.7722 Office
Editor@CannabisNewsWire.com

CannabisNewsWire is powered by IBN

420 with CNW — Operators Say Marijuana Incubators Could Boost Equity While Growing Business

A set of fresh marijuana incubators and mentorship initiatives now offer support and practical training to small-scale cannabis brands and newcomers, aiming to promote equity and create opportunities for individuals affected by the consequences of the drug war. In exchange, organizers anticipate gaining advantages from local community ties and affordable labor while also inspiring employees with purpose-driven tasks.

With the decline in available capital in the marijuana sector, most operators feel compelled to accomplish more with limited resources. Oscar Carrillo, who had served four years in prison for drug sales, found it discouraging that large multistate operators (MSOs) dominated the recreational cannabis industry in New Jersey when it first opened for business in 2022.

Carrillo eventually received a social-equity license, which he perceived as validation. However, he encountered new challenges. His venture, Magic Garden Botanicals, funded through his successful telecommunications enterprise, aimed for vertical integration. Yet, obtaining suitable real estate posed a significant obstacle.

Just when Carrillo’s intentions to purchase beachfront real estate in Penns Grove, New Jersey, failed, he met Cannabiz Incubator founder Alan Trzuskoski. Trzuskoski was seeking tenants from various segments of the marijuana supply chain for his new establishment in Bridgeton, New Jersey. Inspired by his experiences in the Silicon Valley tech industry, Trzuskoski currently operates Cannabiz Incubator as a landlord offering consulting services, intending to turn the operation into an accelerator model.

Recognizing real estate as a major obstacle for startups, Trzuskoski concentrated on obtaining property in Bridgeton, an area designated for impact, and obtained permission from the local government to house up to 15 companies at the Cannabiz Incubator location. He currently rents the space to 6 tenants. His ultimate goal is to create an ecosystem of more manageable, resource-constrained businesses that can take on the market leaders.Aspiring business owners and those who have previously engaged in the markets sometimes have close relationships with the community, which allows them to customize their services.

For example, Carrillo intends to take advantage of the popularity of outlet stores in New Jersey by providing low-cost cannabis items in nonbranded packaging in a dispensary designed to resemble one.

Elsewhere, Zenbarn Farms, based in Waterbury Center, Vermont, expanded its presence by acquiring various marijuana facilities from the departing Curaleaf Holdings, focusing on regenerative farming practices to align with local preferences. With funding from the Pennywise Foundation, the founders hope to grow their incubator program to offer extensive knowledge in the whole supply chain while highlighting reciprocal benefits through worker development programs. The new owners intend to use live soil and wildflowers planted around the greenhouse’s perimeter to broaden their regenerative farming practices to cater more to local interests as farmers.

Meanwhile, in Humboldt County, Cookies, a California marijuana brand that operates Cookies University, hosts five students every summer under strict social-equity criteria. The program, led by industry veterans such as Lindsey Renner, immerses students in all aspects of the supply chain during two months, providing an alternative to entrepreneurship for those more inclined towards employment in retail, manufacturing and cultivation.

After graduation, some students stay on to work with Cookies, while others land jobs at other cannabis companies. Others go back to their old markets or carry on with their activism in areas where marijuana is still illegal.

As more people access the kind of training that the likes of Cookies University offers, industry actors such as SNDL Inc. (NASDAQ: SNDL) could have a sizeable pool of well-trained job seekers to choose from.

About CNW420

To receive SMS alerts from CNW, text CANNABIS to 888-902-4192 (U.S. Mobile Phones Only)

For more information, please visit https://www.CannabisNewsWire.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: https://www.CannabisNewsWire.com/Disclaimer

CannabisNewsWire
Denver, CO
www.CannabisNewsWire.com
303.498.7722 Office
Editor@CannabisNewsWire.com

CannabisNewsWire is powered by IBN

420 with CNW — Virginia Senate Committee Advances Cannabis Sales Bill as Deadline Looms

Last week, the Virginia Rehabilitation and Social Services Senate Committee passed a proposal to legalize commercial cannabis sales by a 10 to 5 vote. The bill, SB 448, introduced by Senator Aaron Rouse, aims to initiate the licensing of recreational cannabis businesses starting this July. However, retail licenses would not be accessible until next year.

Subject to voter approval, the measure gives local governments the authority to potentially outlaw commercial marijuana operations.

SB 448 will move on to the Senate’s justice committee next week. Subsequently, it will undergo evaluation in the finance committee, where a crucial deadline of Feb. 5, 2024, looms to keep it in contention. There’s also a crossover date of Feb. 13, 2024, that requires the senate to forward the bill to the house, which is also considering a marijuana sales measure of its own.

During a senate marijuana subcommittee hearing, Rouse’s bill prevailed over an opposing proposal from Senator Adam Ebbin, SB 423. Ebbin’s proposal, which aimed to accelerate adult-use marijuana sales through already-existing dispensaries, was rejected due to worries about possible market dominance by well-established companies.

SB 448 outlines licensing for five business categories, including testing laboratories, cultivators, retailers, manufacturers and transporters. The entities would fall under the regulatory purview of the state’s existing CCA.

Legislators have refrained from debating the bill’s tax components or criminal justice legislation effects thus far, delegating those discussions to the senate’s fiscal and judicial committees.

One amendment suggested during last week’s session is a definition of cultivator size measurement. Cannabis advocates suggest replacing the bill’s maximum of 2,000 plants for the largest cultivators with a cap on canopy square area. However, Rouse objected to this change, claiming that plant counts are simpler to monitor and give small companies greater flexibility.

The subcommittee meeting included a significant amount of debate on social-justice provisions, which emphasized priority licensing for veterans, hemp producers and people from low-income and over-policed communities. Changes that were covered in previous subcommittee sessions included doing away with a clause that prohibited legislators from working in the marijuana industry and forbidding law enforcement from being involved in the business. Additional changes addressed issues such as fairness standards for veterans, testing licensing restrictions to prevent lab shopping and concerns for those impacted by the drug war.

Additionally, the proposal addresses the qualifying standards for marijuana company licenses, prohibiting those with felonies or other convictions involving moral conduct from applying for seven years. There were requests to shorten this exclusion period during the subcommittee meeting.

The legislation arrives against the backdrop of Virginia’s existing legal framework, where recreational cannabis possession, use and personal cultivation are already permitted. Originally a Democrat-controlled legislation from 2021, the framework ran into difficulties due to GOP control over the governor’s office and the house later in the year. The unlicensed market has since expanded as a result of the lack of a newly adopted regulatory framework.

Even if Democrats took back control of both chambers of Congress in November, it is still difficult to pass laws on marijuana sales. There are challenges in reaching a consensus among Democrats and possible resistance from Virginia Governor Glenn Youngkin. Gov. Youngkin has voiced his distaste for cannabis reform and highlighted particular issues, such as labor union regulations for cannabis-related enterprises. Although he first seemed receptive to the notion of commercial sales, more subsequent remarks appear to indicate a change in perspective.

The entire cannabis industry, including sector players such as SNDL Inc. (NASDAQ: SNDL), hope that the launch of adult-use cannabis sales in Virginia happens on schedule so that the residents who aspire to consume this substance can find legal sources to access it.

About CNW420

CNW420 spotlights the latest developments in the rapidly evolving cannabis industry through the release of two informative articles each business day. Our concise, informative content serves as a gateway for investors interested in the legalized cannabis sector and provides updates on how regulatory developments may impact financial markets. Articles are released each business day at 4:20 a.m. and 4:20 p.m. Eastern – our tribute to the time synonymous with cannabis culture. If marijuana and the burgeoning industry surrounding it are on your radar, CNW420 is for you! Check back daily to stay up-to-date on the latest milestones in the fast -changing world of cannabis.

To receive SMS alerts from CNW, text CANNABIS to 888-902-4192 (U.S. Mobile Phones Only)

For more information, please visit https://www.CannabisNewsWire.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: https://www.CannabisNewsWire.com/Disclaimer

CannabisNewsWire
Denver, CO
www.CannabisNewsWire.com
303.498.7722 Office
Editor@CannabisNewsWire.com

CannabisNewsWire is powered by IBN

420 with CNW — Several Bills to Legalize Cannabis Filed in Indiana

The potential legalization of cannabis in Indiana is expected to be a prominent issue in the upcoming legislative session. In previous years, legislators have pointed to the proximity of neighboring states with legalized cannabis as a driving force behind Indiana’s consideration of the matter. The allure of increased tax revenue, witnessed in nearby states such as Michigan and Illinois, serves as a persuasive incentive for lawmakers to contemplate legalization.

Currently, nine measures in both the Indiana senate and house have been proposed, with each incorporating “marijuana” in their titles.

SB 99, sponsored by Senators Rodney Pol and Fady Qaddoura, proposes allowing marijuana use for individuals aged 21 years and older or those with serious medical conditions. Additionally, it introduces an excise tax on cannabis.

SB107, proposed by Senators Qaddoura and David Niezgodski, proposes the establishment of a legal framework for the growth and distribution of marijuana in the state.

SB 126, put forth by Senator Greg Taylor, seeks to create a medical cannabis program, enabling doctors to prescribe the substance for specific medical conditions. The bill also proposes the formation of a regulatory committee and the repeal of certain taxes related to cannabis.

SB 294, authored by Senator Eric Bassler, proposes removing cannabis from Schedule I of the controlled substance list. It suggests permitting medical cannabis use for individuals with serious medical conditions, prescribed by a healthcare professional. Similar to Senate Bill 126, SB 294 proposes the establishment of a state marijuana commission to oversee the program.

HB 1146, introduced by Representative Jim Lucas, aims to establish a program allowing medical cannabis growth, testing, processing and distribution by licensed operators. Additionally, the measure makes it illegal to discriminate against people who use medicinal cannabis and also provides legal assistance to anyone found operating a car while under the influence of cannabis.

Representative Blake Johnson’s HB1282 aims to provide guidelines for Indiana’s legal marijuana cultivation and sales. House Bills 1349 and 1350, both authored by Representatives Heath VanNatter, Steve Bartles and Jake Teshka, propose decriminalizing the possession of up to two ounces of cannabis and lays out guidelines for Indiana’s legal marijuana production and distribution, respectively.

Lastly, House Bill 1410 put forth by Representative Zach Payne, would allow the sale and consumption of marijuana to anyone who is at least 18 years of age. It also requires the state’s health department to set up a system for citizens to receive medical cannabis cards, permitting anyone under the age of 18 to use the drug for medical purposes with a prescription. Furthermore, the measure also suggests exempting medical marijuana from the sales tax.

The debate over cannabis legalization in Indiana is expected to change as these proposals move through the legislative process, influenced by factors including taxation, regulations and public health.

Indiana is one of the remaining states that haven’t legalized cannabis in some form, and the progress of the these bills could attract the interest of several cannabis companies, such as SNDL Inc. (NASDAQ: SNDL), as the spread of the reform movement reaches these holdout states.

About CNW420

To receive SMS alerts from CNW, text CANNABIS to 888-902-4192 (U.S. Mobile Phones Only)

For more information, please visit https://www.CannabisNewsWire.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: https://www.CannabisNewsWire.com/Disclaimer

CannabisNewsWire
Denver, CO
www.CannabisNewsWire.com
303.498.7722 Office
Editor@CannabisNewsWire.com

CannabisNewsWire is powered by IBN

420 with CNW — GOP Medical Cannabis Plan in Wisconsin Receives Muted Response

Wisconsin GOP assembly legislators have put forth a proposal aimed at legalizing medical cannabis in the state. The proposal, however, received a tepid response from Governor Tony Evers (D) and senate GOP leaders due to its highly restrictive nature.

Unlike the broader legalization efforts advocated by Democrats and Gov. Evers through the years, the proposed bill focuses on allowing medical cannabis use only for severely ill individuals dealing with chronic diseases such as cancer, glaucoma, HIV/AIDS, chronic pain and nausea. However, the bill introduces certain restrictions, such as limiting distribution to only five state-operated locations and prohibiting the use of smokable cannabis. Instead, various alternative forms of the substance, including liquids, patches, vapors, creams, gels, pills, tinctures, oils, gummies and concentrates, would be permissible. Evers, while expressing support for a medical cannabis program, remained noncommittal about the specifics of the proposal.

For the bill to become law, it must pass both the senate and assembly and receive the governor’s signature. However, the reception from key figures in the senate, including Majority Leader Devin LeMahieu, has been cautious. LeMahieu emphasized the need for thorough vetting before making any decisions on the bill.

Senate Minority Leader Dianne Hesselbein (D) acknowledged the proposal as a small step forward but expressed concerns about its restrictive nature. Meanwhile, Assembly Speaker Robin Vos (R) indicated that the outlined program was the maximum extent to which Republican assembly legislators were willing to go.

The bill entrusts the state’s health services department with determining the exact locations of the five dispensaries. Interestingly, given the legalization of recreational cannabis in neighboring Michigan, Illinois and Minnesota, Wisconsin residents may find closer access to dispensaries in other states. A 2023 report by the Wisconsin Policy Forum highlighted that more than one-half of Wisconsin residents above the age of 21 were within a 75-minute drive of a licensed dispensary in another state.

Under Evers’ 2023 rejected full-legalization proposal, Wisconsin anticipated collecting about $165 million annually in sales taxes. However, the current proposed medical cannabis proposal would not contribute to Wisconsin sales tax revenue.

The bill specifies that patients seeking medical cannabis must have a physician’s diagnosis and can obtain the cannabis only from one of the five state-operated dispensaries. Wisconsin stands out as an outlier nationally, with 38 states legalizing medical cannabis and 24 legalizing recreational cannabis. The momentum for legalization in Wisconsin has grown as neighboring states have relaxed their cannabis legalization laws.

Established enterprises such as SNDL Inc. (NASDAQ: SNDL) and the broader cannabis industry will be watching to see how the regulatory landscape in Wisconsin will shape up in the coming months leading to the November polls.

About CNW420

To receive SMS alerts from CNW, text CANNABIS to 888-902-4192 (U.S. Mobile Phones Only)

For more information, please visit https://www.CannabisNewsWire.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: https://www.CannabisNewsWire.com/Disclaimer

CannabisNewsWire
Denver, CO
www.CannabisNewsWire.com
303.498.7722 Office
Editor@CannabisNewsWire.com

CannabisNewsWire is powered by IBN

420 with CNW — Federal Lawsuit Challenges Cannabis Advertising Ban in Mississippi

Clarence Cocroft, the owner of Tru Source, a medical marijuana dispensary in Olive Branch, Mississippi, is contending that the ban on medical marijuana advertising in Mississippi is hindering his dispensary’s ability to attract customers. He claims that this prohibition infringes upon his freedom of speech, a claim central to the federal suit filed on Nov. 14, 2023.

The lawsuit targets the regulatory authorities overseeing these restrictions, including the state’s health department, the revenue department, and the state’s bureau of alcohol and beverage control.

While medical cannabis is now legal in Mississippi for persons with qualifying conditions and a medical marijuana card, the state law explicitly forbids dispensary owners and cultivators from promoting marijuana products. To establish a medical marijuana shop, one is required to obtain a dispensary license, obtain a sales tax registration and incur considerable fees. Additionally, patrons must possess a medical marijuana card and be at least 21 years old to enter a dispensary.

Tru Source relies on limited advertising channels, including word of mouth, on-location signage and its website. Cocroft, however, faces restrictions preventing him from promoting the dispensary through other mediums. He highlights that potential customers might remain unaware of the store’s existence unless they happen to pass by.

Represented by the Institute for Justice (IJ), a nationwide libertarian nonprofit law firm, Cocroft’s lawsuit challenges the constitutionality of commercial speech regulations. Katrin Marquez, an attorney for Cocroft, points out how these regulations, viewed through the lens of the First Amendment, impede business growth.

When Tru Source was established, Cocroft invested in billboards in the north of the state for advertising but had to lease the locations to other businesses, such as a casino, capable of legally promoting their products. The case and the resultant media attention have attracted new customers to Tru Source, increasing daily visits from about 15 to 20 patients to 20 to 30 patients picking up medical marijuana products.

Cocroft argues that the ban on advertising not only affects dispensary owners but also impacts cultivators. If dispensaries can’t promote products, their purchasing capacity diminishes, causing financial losses for cultivators. He questions the disparity, noting that industries such as alcohol, medications, casinos and strip clubs can advertise statewide, while marijuana dispensaries face restrictions.

Cocroft highlights the financial burden borne by those invested in Mississippi’s medical marijuana industry, where millions of dollars have been spent in pursuit of helping patients navigate a novel business landscape. In his view, the unequal advertising regulations create a puzzling dichotomy where certain industries can freely advertise, while others, such as Tru Source, face stringent limitations.

It isn’t just cannabis companies in Mississippi that are hamstrung by restrictions on advertising. Other enterprises operating elsewhere, such as SNDL Inc. (NASDAQ: SNDL), are also grappling with limitations on how and where they can advertise their products.

About CNW420

To receive SMS alerts from CNW, text CANNABIS to 888-902-4192 (U.S. Mobile Phones Only)

For more information, please visit https://www.CannabisNewsWire.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: https://www.CannabisNewsWire.com/Disclaimer

CannabisNewsWire
Denver, CO
www.CannabisNewsWire.com
303.498.7722 Office
Editor@CannabisNewsWire.com

CannabisNewsWire is powered by IBN

420 with CNW — Study Suggests CBD-Infused Tampons Could Be Effective Against Menstrual Pain

A recent study published in the “Endometriosis and Uterine Disorders” Journal has unveiled promising results regarding CBD-infused tampons for alleviating menstrual pain and severe cramps. The study’s authors posit that these CBD-infused tampons may present a more favorable option with fewer side effects compared to traditional anti-inflammatory medications, offering a parallel pain-relieving impact.

The research team, comprised of six researchers, noted the following in their report: “The outcomes suggest that CBD-infused tampons hold potential as an effective solution for managing menstrual pain.” They emphasized the necessity for further exploration and research into the product, asserting its potential contribution to addressing primary dysmenorrhea, a condition characterized by painful muscle cramps and spasms affecting between 50% and 90% of menstruating women.

The study examined the relationship between CBD, CB2 and CB1 receptors, claiming that because these receptors are extensively dispersed throughout uterine tissue, they provide an ideal target for the localized administration of cannabinoids to reduce pain. A randomized, placebo-controlled methodology was used to conduct the study, and participants were not informed whether they were using a regular or CBD-infused tampon. Participants self-reported their pain thresholds and general levels of satisfaction.

The study group carefully investigated a number of factors, such as systemic toxicity, vaginal irritation, material-mediated pyrogenicity, sensitization, and possible risk of toxic shock syndrome. They confirmed that every test was passed with success, demonstrating the safety of tampons infused with CBD.

Regarding pain alleviation, the report indicated a noteworthy percentage change, reaching 100% in the last menstruation days. Additionally, the study demonstrated a statistically significant decrease in discomfort during particular days of the menstrual cycle, two hours after tampon application.

Although fewer than 5% of participants reported experiencing irritation as a result of using CBD-infused tampons, between 37% and 40% reported an improvement in their vaginal dryness. Two patients reported vertigo while using the product; however, the symptoms cleared promptly without the need for medical treatment after removing the tampon.

The study’s lead author, Valentina Milanova, who also serves as CEO of Daye, a gynecological research company that claims to offer the first CBD-infused tampon worldwide, stated that the observed alleviation of primary dysmenorrhea throughout the menstrual cycle supports the potential effectiveness of CBD-infused tampons. All authors have financial ties to Daye’s parent company, Anne’s Day Ltd., based in London.

The authors did note the study’s shortcomings, particularly its small sample size, and urged future research and improvements to the research design, including the use of a crossover design to collect full pain data.

Cannabis research is still relatively in its infancy, but as the years go by, much more is likely to be known about the health and wellness benefits of the marijuana products currently commercialized by entities such as SNDL Inc. (NASDAQ: SNDL).

About CNW420

To receive SMS alerts from CNW, text CANNABIS to 888-902-4192 (U.S. Mobile Phones Only)

For more information, please visit https://www.CannabisNewsWire.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: https://www.CannabisNewsWire.com/Disclaimer

CannabisNewsWire
Denver, CO
www.CannabisNewsWire.com
303.498.7722 Office
Editor@CannabisNewsWire.com

CannabisNewsWire is powered by IBN

420 with CNW — Missouri Expunges 100K Marijuana Cases in Year One of Legal Cannabis Sales

Recent data shows that officials in the state of Missouri have thus far expunged more than 100,000 cannabis cases from court records. Under the law, misdemeanors had to be automatically expunged by June 8, 2023, and felonies had to be cleared by Dec. 8, 2023. The deadline for felony expungements, which lapsed last week, wasn’t met by all courts, however, with clerks still reviewing decades of old cases.

In an interview, Dan Viets, a lawyer and coordinator of Missouri NORML, stated that courts would need additional time to finish the task and noted that it could be years before all cases from the last 100 years were expunged. Viets, who also coauthored the state’s constitutional amendment legalizing cannabis, added that the state had prohibited cannabis for more than a century and, given that most older cases hadn’t been updated on a database, a lot of physical work was needed to find and go through hard-copy records.

In a press release of the state’s NORML chapter, Viets noted that the provision on automatic expungement was a significant part of Missouri’s marijuana law that was approved by voters in 2022. Missouri NORML also highlighted that the ballot proposal, now codified as Article XIV in the state’s constitution, provided funds for the expungement via the 6% sales tax imposed on recreational cannabis.

The organization explained that the tax had generated more revenue than was needed to pay overtime to existing staff or fund the hiring of more staff in the offices of circuit clerks across Missouri. In November, total cannabis sales in the state exceeded the $1 billion mark, with legislators announcing recently that of the total taxes generated, $17 million would fund drug treatment, veterans’ health and legal aid.

Viets also noted that counties that missed the December deadline were in violation of Missouri’s constitution and legal action could be taken. He then revealed that about six of the counties in the state hadn’t expunged any cases on misdemeanor violations, asserting that these were smaller counties where Amendment 3’s support wasn’t as high.

On a broader scale, the state’s cannabis system has experienced significant hitches this year, with thousands of products being recalled over the illegal use of cannabinoids derived from hemp. In November, officials revoked Delta Extraction’s business license, as the company was at the center of the aforementioned dispute.

Another company, Retailer Point Management, also had to settle a dispute with a union over more than 10 charges of unfair labor practices. All this is part of a wider push by workers at marijuana businesses to organize the industry.

These ongoing expungements are likely being watched closely by the entire cannabis industry, including companies such as SNDL Inc. (NASDAQ: SNDL), given that times have changed and there is a growing consensus that no one should suffer lifelong consequences for being convicted after using a substance that is now legal in a significant portion of the United States as well as several countries around the world.

About CNW420

To receive SMS alerts from CNW, text CANNABIS to 888-902-4192 (U.S. Mobile Phones Only)

For more information, please visit https://www.CannabisNewsWire.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: https://www.CannabisNewsWire.com/Disclaimer

CannabisNewsWire
Denver, CO
www.CannabisNewsWire.com
303.498.7722 Office
Editor@CannabisNewsWire.com